early laryngeal cancer is a well known field with great controversy in treatment. two
options are available in treatment of patients the first one is partial laryngectomy and the
second one is radiotherapy.one of major concern of patients have been the quality of voice
as part of quality of life ,so we design this clinical randomised trial to answer the
priority of each options.
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
quality of voice
3 to 6 month after therapy
No
babak saedi, professor
Principal Investigator
tehran university of medical science
Iran: TUMS ethics committee
bs-86-01-48-5497
NCT00497588
March 2007
December 2012
Name | Location |
---|